Skip to main content
. Author manuscript; available in PMC: 2010 Feb 22.
Published in final edited form as: Neurobiol Aging. 2007 Sep 21;30(4):607–614. doi: 10.1016/j.neurobiolaging.2007.08.003

Table 2a.

Odds of developing cognitive impairment (unadjusted and multivariate adjusted for age, education and baseline cognition) over 4 years by ESR1 and ESR2 single nucleotide polymorphism genotype in women.

ESR1 SNP
Genotype
N With
Genotype
%
Impaired
Unadjusted
OR (95% CI)
Multivariate
OR (95% CI)
ESR2 SNP
Genotype
N With
Genotype
%
Impaired
Unadjusted
OR (95% CI)
Multivariate
OR (95% CI)
rs8179176 rs1255998
GG 151 19 0.61 (0.40-0.94) 0.65 (0.42-1.01) GG 171 33 1.51 (1.06-2.13) 1.25 (0.87-1.80)
AA or AG 1163 27 1.0 (ref) 1.0 (ref) CC or CG 1131 25 1.0 (ref) 1.0 (ref)

rs9340799 rs1256065
GG 335 22 0.76 (0.57-1.02) 0.73 (0.54-0.99) CC 144 16 0.51 (0.32-0.81) 0.56 (0.35-0.88)
AA or AG 965 27 1.0 (ref) 1.0 (ref) AA or AC 1155 27 1.0 (ref) 1.0 (ref)

rs3728524 rs1256049
GG or GA 255 31 1.33 (0.98-1.80) 1.23 (0.90-1.70) AA or AG 134 32 1.39 (0.94-2.04) 1.24 (0.83-1.85)
AA 1052 25 1.0 (ref) 1.0 (ref) GG 1181 25 1.0 (ref) 1.0 (ref)

rs3798577 rs1256030
CC 1007 26 1.04 (0.77-1.39) 1.08 (0.80-1.46) TT 197 18 0.58 (0.39-0.85) 0.64 (0.43-0.94)
TT or TC 299 26 1.0 (ref) 1.0 (ref) CC or CT 1108 27 1.0 (ref) 1.0 (ref)

Most common allele frequencies: ESR1 rs8179176 A=58%, rs9340799 A=50%, rs728524 A=88%, rs3798577 T=53%; ESR2 rs1255998 C=70%, rs1256065 A=72%, rs1256049 G=95%, rs1256030 C=64%.